MedicinePharmacologyPharmacotherapyClinical PharmacologyMolecular VirologyVirologyAntiviral AgentsAntiviral ImmunityAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyAntiviral Adverse EffectsAntiviral Natural ProductsAntiviral TherapeuticsAntiviral TreatmentBaseline Hiv TestingBaseline Laboratory TestingViral Load AssaysViral Load Assessment
A New England clinical trial examined curcumin and its effectiveness as an antiviral agent in 40 participants. Viral load tests, including baseline testing, were conducted in the fourth and eighth weeks, following high- and low-dose regimens. The study found no evidence that curcumin reduced viral load or increased CD4 counts. Despite this finding, patients claimed they liked taking curcumin because they felt better and were willing to put up with the minor gastrointestinal effects.